Harvey Robert Klingensmith - Apr 1, 2023 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role
Director
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Stock symbol
CLB
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4
Date filed
4/3/2023, 01:36 PM
Previous filing
Apr 4, 2022
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Options Exercise $0 +5.49K +26.45% $0.00 26.2K Apr 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Restricted Shares Award $0 +6.42K $0.00 6.42K Apr 1, 2023 Common Shares 6.42K $0.00 Direct F1
transaction CLB Restricted Shares Options Exercise $0 -5.49K -100% $0.00* 0 Apr 1, 2023 Common Shares 5.49K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance.
F2 The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023.